In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapies

BACKGROUND: Immunotherapeutic innovation is crucial for limited operability tumors. CAR T-cell therapy displayed reduced efficiency against glioblastoma (GBM), likely due to mutations underlying disease progression. Natural Killer cells (NKs) detect cancer cells despite said mutations – demonstratin...

Descripción completa

Detalles Bibliográficos
Autores principales: Galat, Yekaterina, Du, Yuchen, Perepitchka, Mariana, Li, Xiao-Nan, Balyasnikova, Irina V, Tse, William T, Dambaeva, Svetlana, Schneiderman, Sylvia, Iannaccone, Philip M, Becher, Oren, Graham, Douglas K, Galat, Vasiliy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501168/
https://www.ncbi.nlm.nih.gov/pubmed/37720687
http://dx.doi.org/10.1080/2162402X.2023.2240670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501168/
https://www.ncbi.nlm.nih.gov/pubmed/37720687
http://dx.doi.org/10.1080/2162402X.2023.2240670

Ejemplares similares